home / stock / ibb / ibb news


IBB News and Press, iShares Biotechnology ETF From 05/20/22

Stock Information

Company Name: iShares Biotechnology ETF
Stock Symbol: IBB
Market: NASDAQ

Menu

IBB IBB Quote IBB Short IBB News IBB Articles IBB Message Board
Get IBB Alerts

News, Short Squeeze, Breakout and More Instantly...

IBB - Novavax falls as Bank of America issues its only sell-equivalent rating

Novavax (NASDAQ:NVAX) is trading sharply lower in the morning hours Friday after Bank of America initiated its coverage, issuing the COVID-19 vaccine maker its only Sell equivalent rating on Wall Street. BofA analyst Alec W. Stranahan points out that Novavax (NVAX) has lost 59% in the year so...

IBB - Greenwich LifeSciences: A First Look

Shares of Greenwich LifeSciences, Inc. are trading near their lowest levels since the stock exploded upward in December 2020 in what was an illustrative example of an inefficient market. A still-pending Phase 3 study launch for its only asset in the treatment of breast cancer that was...

IBB - argenx SE: Again Following Dutch Biotech, Prior Recommendation Near-Term Gain

Derivatives markets, used by the market-making community to hedge equity market liquidity trade orders, tell by their component structure and prices the subject stock’s expected coming price range limits. By comparing today’s balance of upside and downside price change p...

IBB - Novavax: Buying Here Will Not End Well

Novavax reported an underwhelming Q1 earnings card. Despite reiterating its FY22 guidance, the consensus estimates have been downgraded. The market is losing confidence in management's ability to deliver. Therefore, if Novavax continues to miss the estimates, we believe it could lead ...

IBB - Organogenesis Holdings: What Now

Today, we revisit advance wound care name Organogenesis Holdings for the first time since late in 2020. This small cap healthcare concern is already profitable and continues to build out its product portfolio. A full investment analysis follows in the paragraphs below. For f...

IBB - Exelixis: Becoming A Giant Pharma

Over the years, Exelixis' esteemed management successfully ramped up cabozantinib sales beyond the blockbuster range. Through many ongoing aggressive cabozantinib advancements, you can expect this blockbuster to grow by several more folds in revenue in the next few years. Meanwhil...

IBB - 3 Oversold Dividend Stocks to Buy Now

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Oversold dividend stocks present an attractive opportunity to buy into steady, assured income streams at bargain prices Western Union ( WU ): Consistent dividend payor even amid the slowdown engendered by geopoliti...

IBB - Penny Stocks To Buy In May? 3 To Watch Before Next Week

If you’re looking for penny stocks to buy , this market offers incredible opportunities. With how stock market volatility has been this month, a fast hand and a keen eye are crucial. When they say that this is a stock picker’s market, “they” most likely mean ...

IBB - Panic On Wall Street

There is a crash unfolding. The S&P 500 has the worst YTD performance since 1962 and bearish sentiment is highest since the Great Recession. There are different approaches to investing, but I invest for the long term, and I add money to my portfolio every two weeks. The best t...

IBB - Investing For Growth In A Decelerating World Economy

With the world facing inflationary and geopolitical hurdles, economic growth is poised to slow. Shares across sectors have been hit hard. Investors in growth stocks must identify companies with the right features to overcome headwinds to earnings. For further details see: ...

Previous 10 Next 10